Imperial Chemical Industries Limited

Edwin Harry Young

Ronald Hilson Galt

The disclosure relates to new 2-(substituted anilino)methylmorpholine derivatives which possess antidepressant activity, to processes for the manufacture of the said morpholine derivatives and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(2-ethoxyanilino)methylmorpholine.

Morpholine derivatives for treating depression

The disclosure relates to thioxanthene derivatives which possess analgesic activity, to processes for the manufacture of said derivatives and to pharmaceutical compositions containing them. Typical of the thioxanthene derivatives disclosed is 4-acetoxy-6-chloro-1'-methylthioxanthene-9-spiro-4'-piperidine.

1'-Substituted-thioxanthene-9-spiro-4'-piperidine derivatives and the

The disclosure relates to new 2-(substituted anilino)-methylmorpholine derivatives which possess sedative activity, to processes for the manufacture of the said morpholine derivatives, and to pharmaceutical compositions containing them. Typical of the morpholine derivatives disclosed is 2-(3-methoxyanilino)methylmorpholine.

Growing community of inventors

Macclesfield, United Kingdom

Edwin Harry Young